1. Home
  2. AMRX vs BWIN Comparison

AMRX vs BWIN Comparison

Compare AMRX & BWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • BWIN
  • Stock Information
  • Founded
  • AMRX 2002
  • BWIN 2011
  • Country
  • AMRX United States
  • BWIN United States
  • Employees
  • AMRX N/A
  • BWIN N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • BWIN Specialty Insurers
  • Sector
  • AMRX Health Care
  • BWIN Finance
  • Exchange
  • AMRX Nasdaq
  • BWIN Nasdaq
  • Market Cap
  • AMRX 2.4B
  • BWIN 2.9B
  • IPO Year
  • AMRX N/A
  • BWIN 2019
  • Fundamental
  • Price
  • AMRX $8.38
  • BWIN $44.69
  • Analyst Decision
  • AMRX Strong Buy
  • BWIN Buy
  • Analyst Count
  • AMRX 5
  • BWIN 8
  • Target Price
  • AMRX $10.80
  • BWIN $44.43
  • AVG Volume (30 Days)
  • AMRX 1.8M
  • BWIN 685.6K
  • Earning Date
  • AMRX 05-02-2025
  • BWIN 05-06-2025
  • Dividend Yield
  • AMRX N/A
  • BWIN N/A
  • EPS Growth
  • AMRX N/A
  • BWIN N/A
  • EPS
  • AMRX N/A
  • BWIN N/A
  • Revenue
  • AMRX $2,793,957,000.00
  • BWIN $1,389,037,000.00
  • Revenue This Year
  • AMRX $10.49
  • BWIN $13.39
  • Revenue Next Year
  • AMRX $7.00
  • BWIN $13.65
  • P/E Ratio
  • AMRX N/A
  • BWIN N/A
  • Revenue Growth
  • AMRX 16.73
  • BWIN 13.99
  • 52 Week Low
  • AMRX $5.18
  • BWIN $26.08
  • 52 Week High
  • AMRX $9.48
  • BWIN $55.82
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 46.15
  • BWIN 58.50
  • Support Level
  • AMRX $8.18
  • BWIN $44.04
  • Resistance Level
  • AMRX $8.95
  • BWIN $46.57
  • Average True Range (ATR)
  • AMRX 0.31
  • BWIN 1.80
  • MACD
  • AMRX -0.08
  • BWIN 0.40
  • Stochastic Oscillator
  • AMRX 23.40
  • BWIN 70.61

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About BWIN The Baldwin Insurance Group Inc. Class A Common Stock

The Baldwin Insurance Group Inc is a United States-based insurance distribution firm. Its products include Business Insurance, Benefits Consulting, Reinsurance, Specialty MGA, Embedded Insurance., Personal insurance, etc.

Share on Social Networks: